Beth J Hoffman

Beth J Hoffman Email and Phone Number

Founder & CEO of Origami Therapeutics, Inc. (YC W22) @ Vertex Pharmaceuticals, Inc.
Greater San Diego Area
Beth J Hoffman's Location
San Diego, California, United States, United States
About Beth J Hoffman

I’m a Research and Development Executive in drug discovery and development, with a consistent record of successfully generating and implementing research strategies for multiple disease areas from early target identification and validation through clinical Proof-of-Concept (POC), increasing quality, productivity and innovation.I have extensive expertise in evaluating partnership and investment opportunities for small molecules, biologics and nucleic acid therapeutics.I’m an internationally recognized scientist generating cutting-edge research in neuroscience, respiratory diseases, regenerative medicine, pharmacology, molecular biology, and cellular signaling pathways, with a strong publication record. Skills include:• Establishing New Therapeutic & Disease Areas • Pioneer in Applying Disruptive Technologies to Drug Discovery • Building High-Performing Cross-Functional Teams • Generating Collaborative Networks of Industrial & Academic Partnerships• Strategic Planning • Focusing on Precision Medicine

Beth J Hoffman's Current Company Details
Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

View
Founder & CEO of Origami Therapeutics, Inc. (YC W22)
Greater San Diego Area
Website:
vrtx.com
Employees:
6088
Beth J Hoffman Work Experience Details
  • Vertex Pharmaceuticals, Inc.
    Vertex Pharmaceuticals, Inc.
    Greater San Diego Area
  • Origami Therapeutics, Inc.
    Ceo
    Origami Therapeutics, Inc. Oct 2015 - Present
  • Biofrontera Inc.
    Member Board Of Directors
    Biofrontera Inc. Oct 2021 - Present
    Woburn, Massachusetts, Us
    Biofrontera (BFRI) is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care.
  • The Rainwater Charitable Foundation
    Member, Tau Consortium Scientific Advisoy Board
    The Rainwater Charitable Foundation Jun 2021 - Present
    Fort Worth, Texas, Us
  • Vertex Pharmaceuticals, Inc.
    Vice President, Discovery Biology
    Vertex Pharmaceuticals, Inc. Jul 2007 - Dec 2014
    Boston, Ma, Us
    Drove strategic planning, prioritization and implementation to generate clinical candidates for respiratory and neurological diseases by building biology platforms applicable across disease areas and focusing on underlying cause of disease (precision medicine).
  • Amgen, Inc.
    Scientific Executive Director, Neuroscience
    Amgen, Inc. Aug 2004 - Dec 2006
    Thousand Oaks, Ca, Us
    Built and guided neuropsychiatric drug discovery group (new disease area) including strategic planning, resource allocation, talent recruitment, assay development and translational biomarkers. Elected to Scientific Advisory Board for Amgen Ventures to evaluate Series A and Series B investment opportunities.
  • Eli Lilly & Co
    Head, Neuroscience
    Eli Lilly & Co Sep 1998 - Jul 2004
    Indianapolis, Indiana, Us
    Established new research group from independent subgroups and oversaw strategic planning and execution on novel targets portfolio.
  • National Institute Of Mental Health
    Head, Unit On Molecular Pharmacology
    National Institute Of Mental Health 1988 - 1998
    Bethesda, Md, Us
    Established and directed team to clone neurotransmitter transporters and to study role of neurotransmitter transporters in synaptic physiology. Awarded Anna-Monika Foundation Prize (1993) for the advancement in knowledge about the biological substrate and functional disturbances of depression.

Beth J Hoffman Skills

Neuroscience Drug Discovery Drug Development Biotechnology Life Sciences Pharmacology Pharmaceutical Industry Molecular Biology Biopharmaceuticals Biomarkers Clinical Development Lifesciences Cro Biochemistry Immunology Technology Transfer Commercialization Infectious Diseases Oncology Cancer Stem Cell Research Analytical Chemistry Stem Cell Technology Orphan Diseases 3d Human Cell Models Cystic Fibrosis Respiratory Disease Liver Disease Phenotypic Screening Technologies Huntington's Disease Cro Management

Beth J Hoffman Education Details

  • The Johns Hopkins University
    The Johns Hopkins University
    Cell Biology
  • Wellesley College
    Wellesley College
    Molecular Biology

Frequently Asked Questions about Beth J Hoffman

What company does Beth J Hoffman work for?

Beth J Hoffman works for Vertex Pharmaceuticals, Inc.

What is Beth J Hoffman's role at the current company?

Beth J Hoffman's current role is Founder & CEO of Origami Therapeutics, Inc. (YC W22).

What schools did Beth J Hoffman attend?

Beth J Hoffman attended The Johns Hopkins University, Wellesley College.

What are some of Beth J Hoffman's interests?

Beth J Hoffman has interest in Social Services, Poverty Alleviation, Science And Technology, Arts And Culture, Health.

What skills is Beth J Hoffman known for?

Beth J Hoffman has skills like Neuroscience, Drug Discovery, Drug Development, Biotechnology, Life Sciences, Pharmacology, Pharmaceutical Industry, Molecular Biology, Biopharmaceuticals, Biomarkers, Clinical Development, Lifesciences.

Who are Beth J Hoffman's colleagues?

Beth J Hoffman's colleagues are Kenewe Kaotsane, Annika Bhanot, Belinda Faust, Ron Shmueli, Sarah Martin, Justin Pritchard, Bradley Turchi.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.